AI chatbot helps you track heart, kidney, and metabolic health
Part of Heart & circulation, Hormones & metabolism, Kidney & urinary clinical trials.
This study tests whether an AI chatbot on your phone can help you monitor and manage early heart, kidney, and metabolic problems. The goal is to help you stay healthier through regular symptom tracking and self-care tips.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older
- You have been diagnosed with stage 1 or 2 cardiovascular-kidney-metabolic (CKM) syndrome—a condition affecting your heart, kidneys, and metabolism
- You receive regular outpatient care (visiting a doctor's clinic, not hospitalized)
- You can speak and read Mandarin or Taiwanese
- You own or have regular access to a smartphone or tablet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone and wearable-based health management platform for people with early-stage cardiovascular-kidney-metabolic (CKM) syndrome. It aims to help patients track and improve their health through personalized support.
This study tests if text messages from an AI program can help you improve your heart health habits, like taking medication on time and managing blood pressure, cholesterol, or diabetes.
This trial is testing a new AI chatbot that helps people in Hong Kong manage their health conditions like high blood sugar, high blood pressure, or high cholesterol. If you take medication for one of these conditions or care for someone who does, you may be able to join.
This study is testing a friendly chatbot to help older adults make healthy lifestyle changes. You would use the chatbot on your phone to get tips and support.
This study tests if an AI-powered system can help manage premature coronary artery disease in adults aged 18 to 45. It uses a smartphone app to support treatment and improve outcomes.
This study tests a program that uses WeChat to help people with metabolic syndrome and chronic kidney disease make healthy lifestyle changes. They want to see if this support can improve health and slow down kidney problems.
Hear when a new Cardiovascular-kidney-metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.